Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
267 GBX | -1.11% | 0.00% | +44.32% |
May. 09 | NatWest target raised, other lenders backed | AN |
Apr. 16 | Team17 shares fall; swings to loss as hit by one-off costs | AN |
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's high margin levels account for strong profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Sales forecast by analysts have been recently revised upwards.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The firm trades with high earnings multiples: 29.03 times its 2023 earnings per share.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Sector: Software
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+44.32% | 486M | - | ||
+10.02% | 3,082B | C+ | ||
+8.25% | 84.92B | B | ||
+4.44% | 78.23B | B+ | ||
-14.19% | 54.06B | B+ | ||
-23.14% | 46.79B | B- | ||
+21.64% | 42.68B | D+ | ||
+59.16% | 37.28B | D+ | ||
-10.56% | 24.89B | C+ | ||
+18.21% | 21.93B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- TM17 Stock
- Ratings Team17 Group plc